<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36319681</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome.</ArticleTitle><Pagination><StartPage>18418</StartPage><MedlinePgn>18418</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">18418</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-22107-1</ELocationID><Abstract><AbstractText>Acute Respiratory Distress Syndrome (ARDS) is common in COVID-19 patients and is associated with high mortality. The aim of this observational study was to describe patients' characteristics and outcome, identifying potential risk factors for in-hospital mortality and for developing Long-COVID symptoms. This retrospective study included all patients with COVID-19 associated ARDS (cARDS) in the period from March 2020 to March 2021&#xa0;who were invasively ventilated at the intensive care unit (ICU) of the University Hospital Dresden, Germany. Between October 2021 and December 2021 patients discharged alive (at minimum 6&#xa0;months after hospital discharge-midterm survival) were contacted and interviewed about persistent symptoms possibly associated with COVID-19 as well as the quality of their lives using the EQ-5D-5L-questionnaire. Long-COVID was defined as the occurrence of one of the symptoms at least 6&#xa0;months after discharge. Risk factors for mortality were assessed with Cox regression models and risk factors for developing Long-COVID symptoms by using relative risk (RR) regression. 184 Patients were included in this study (male: n&#x2009;=&#x2009;134 (73%), median age 67 (range 25-92). All patients were diagnosed with ARDS according to the Berlin Definition. 89% of patients (n&#x2009;=&#x2009;164) had severe ARDS (Horovitz-index &lt;&#x2009;100&#xa0;mmHg). In 27% (n&#x2009;=&#x2009;49) extracorporeal membrane oxygenation was necessary to maintain gas exchange. The median length of in-hospital stay was 19&#xa0;days (range 1-60). ICU mortality was 51%, hospital mortality 59%. Midterm survival (median 11&#xa0;months) was 83% (n&#x2009;=&#x2009;55) and 78% (n&#x2009;=&#x2009;43) of these patients presented Long-COVID symptoms with fatigue as the most common symptom (70%). Extreme obesity (BMI&#x2009;&gt;&#x2009;40&#xa0;kg/m<sup>2</sup>) was the strongest predictor for in-hospital mortality (hazard ratio: 3.147, confidence interval 1.000-9.897) and for developing Long-COVID symptoms (RR 1.61, confidence interval 1.26-2.06). In-hospital mortality in severe cARDS patients was high, but&#x2009;&gt;&#x2009;80% of patients discharged alive survived the midterm observation period. Nonetheless, most patients developed Long-COVID symptoms. Extreme obesity with BMI&#x2009;&gt;&#x2009;40&#xa0;kg/m<sup>2</sup> was identified as independent risk factor for in-hospital mortality and for developing Long-COVID symptoms.Trial registration DRKS-ID DRKS00027856.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heubner</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrick</LastName><ForeName>Paul Leon</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ldner</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartels</LastName><ForeName>Lea</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragaller</LastName><ForeName>Maximillian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirus</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rand</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiebel</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Institute of Clinical Chemistry, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyer-Westendorf</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Hematology and Hemostasis, Department of Medicine I Thrombosis Research, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xf6;&#xdf;ler</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Evidence-Based Healthcare (ZEGV), University Hospital "Carl Gustav Carus" and "Carl Gustav Carus" Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Evidence-Based Healthcare (ZEGV), University Hospital "Carl Gustav Carus" and "Carl Gustav Carus" Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Thea</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spieth</LastName><ForeName>Peter Markus</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital "Carl Gustav Carus", Technische Universit&#xe4;t Dresden, Dresden, Germany. peter.spieth@uniklinikum-dresden.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>DRKS</DataBankName><AccessionNumberList><AccessionNumber>DRKS00027856</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="Y">Respiratory Distress Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36319681</ArticleId><ArticleId IdType="pmc">PMC9626466</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-22107-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-22107-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. https://covid19.who.int/ (last cited: [26.04.2022]).</Citation></Reference><Reference><Citation>Sweeney RM, McAuley DF. Acute respiratory distress syndrome. Lancet. 2016;388(10058):2416&#x2013;2430. doi: 10.1016/S0140-6736(16)00578-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00578-X</ArticleId><ArticleId IdType="pmc">PMC7138018</ArticleId><ArticleId IdType="pubmed">27133972</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodie D, Bacchetta M. Extracorporeal membrane oxygenation for ARDS in adults. N. Engl. J. Med. 2011;365(20):1905&#x2013;1914. doi: 10.1056/NEJMct1103720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMct1103720</ArticleId><ArticleId IdType="pubmed">22087681</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroELSO: EuroELSO Survey on ECMO use in Adult COVID-19 Patients in Europe. https://www.euroelsonet/covid-19/covid-19-survey/. Accessed 16 March 2021.</Citation></Reference><Reference><Citation>Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: A systematic review and meta-analysis of observational studies. Anaesthesia. 2020;75(10):1340&#x2013;1349. doi: 10.1111/anae.15201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15201</ArticleId><ArticleId IdType="pubmed">32602561</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards-Belle A, Orzechowska I, Gould DW, Thomas K, Doidge JC, Mouncey PR, Christian MD, Shankar-Hari M, Harrison DA, Rowan KM, et al. COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland. Intensive Care Med. 2020;46(11):2035&#x2013;2047. doi: 10.1007/s00134-020-06267-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06267-0</ArticleId><ArticleId IdType="pmc">PMC7545019</ArticleId><ArticleId IdType="pubmed">33034689</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd1;amendys-Silva SA, Guti&#xe9;rrez-Villase&#xf1;or A, Romero-Gonz&#xe1;lez JP. Hospital mortality in mechanically ventilated COVID-19 patients in Mexico. Intensive Care Med. 2020;46(11):2086&#x2013;2088. doi: 10.1007/s00134-020-06256-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06256-3</ArticleId><ArticleId IdType="pmc">PMC7527144</ArticleId><ArticleId IdType="pubmed">33000290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Res. 2020;191:9&#x2013;14. doi: 10.1016/j.thromres.2020.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7177070</ArticleId><ArticleId IdType="pubmed">32353746</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari, H., Gupta, S., Leaf, R.K., Wang, W., Rosovsky, R.P., Brenner, S.K., Hayek, S.S., Berlin, H., Kapoor, R., Shaefi, S. et al. Thrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19. Ann. Internal Med. M20-6739 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7863679</ArticleId><ArticleId IdType="pubmed">33493012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse JM, Magomedov A, Kurreck A, M&#xfc;nch FH, Koerner R, Kamhieh-Milz J, Kahl A, Gotthardt I, Piper SK, Eckardt KU, et al. Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis. Crit. Care (Lond. Engl.) 2020;24(1):676. doi: 10.1186/s13054-020-03401-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03401-8</ArticleId><ArticleId IdType="pmc">PMC7719734</ArticleId><ArticleId IdType="pubmed">33287877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortus JR, Manek SE, Brubaker LS, Loor M, Cruz MA, Trautner BW, Rosengart TK. Thromboelastographic results and hypercoagulability syndrome in patients with coronavirus disease 2019 who are critically ill. JAMA Netw. Open. 2020;3(6):e2011192. doi: 10.1001/jamanetworkopen.2020.11192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.11192</ArticleId><ArticleId IdType="pmc">PMC7275245</ArticleId><ArticleId IdType="pubmed">32501489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluge, S., Janssens, U., Welte, T., Weber-Carstens, S., Sch&#xe4;lte, G., Salzberger, B., Gastmeier, P., Langer, F., Welper, M., Westhoff, M. et al. Recommendations for treatment of critically ill patients with COVID-19: Version 3 S1 guideline. Der Anaesthesist. 1&#x2013;11 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444177</ArticleId><ArticleId IdType="pubmed">32833080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N. Engl. J. Med. 2020;383(2):120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S. Pulmonary embolism in patients with COVID-19: Awareness of an increased prevalence. Circulation. 2020;142(2):184&#x2013;186. doi: 10.1161/CIRCULATIONAHA.120.047430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047430</ArticleId><ArticleId IdType="pubmed">32330083</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauvel C, Weizman O, Trimaille A, Mika D, Pommier T, Pace N, Douair A, Barbin E, Fraix A, Bouchot O, et al. Pulmonary embolism in COVID-19 patients: A French multicentre cohort study. Eur. Heart J. 2020;41(32):3058&#x2013;3068. doi: 10.1093/eurheartj/ehaa500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa500</ArticleId><ArticleId IdType="pmc">PMC7528952</ArticleId><ArticleId IdType="pubmed">32656565</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MFH, Al-Shokri SD, Shunnar KM, Mohamed SF, Najim MS, Ibrahim SI, Elewa H, Abdalla LO, El-Bardissy A, Elshafei MN, et al. Prevalence of venous thromboembolism in critically ill COVID-19 patients: Systematic review and meta-analysis. Front. Cardiovasc. Med. 2021;7:598846. doi: 10.3389/fcvm.2020.598846.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.598846</ArticleId><ArticleId IdType="pmc">PMC7874113</ArticleId><ArticleId IdType="pubmed">33585578</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y., Cai, J., Wang, C., Jin, J., Qu, L. The incidence, prognosis and laboratory indicators of venous thromboembolism in hospitalized patients with COVID-19: A Systematic review and meta-analysis. J. Vasc. Surg. Venous Lymphat. Disord. (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847192</ArticleId><ArticleId IdType="pubmed">33529719</ArticleId></ArticleIdList></Reference><Reference><Citation>Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, M&#xfc;ller MCA, Bouman CCS, Beenen LFM, Kootte RS, Heijmans J, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost. 2020;18(8):1995&#x2013;2002. doi: 10.1111/jth.14888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14888</ArticleId><ArticleId IdType="pmc">PMC7497052</ArticleId><ArticleId IdType="pubmed">32369666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachler, M., B&#xf6;sch, J., St&#xfc;rzel, D.P., Hell, T., Giebl, A., Str&#xf6;hle, M., Klein, S.J., Sch&#xe4;fer, V., Lehner, G.F., Joannidis, M, et al. Impaired fibrinolysis in critically ill COVID-19 patients. Br. J. Anaesthesia. (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833514</ArticleId><ArticleId IdType="pubmed">33422287</ArticleId></ArticleIdList></Reference><Reference><Citation>Nougier C, Benoit R, Simon M, Desmurs-Clavel H, Marcotte G, Argaud L, David JS, Bonnet A, Negrier C, Dargaud Y. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis. J. Thromb. Haemost. 2020;18(9):2215&#x2013;2219. doi: 10.1111/jth.15016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15016</ArticleId><ArticleId IdType="pmc">PMC7405476</ArticleId><ArticleId IdType="pubmed">32668058</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb. Res. 2020;194:101&#x2013;115. doi: 10.1016/j.thromres.2020.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.06.029</ArticleId><ArticleId IdType="pmc">PMC7305763</ArticleId><ArticleId IdType="pubmed">32788101</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 2020;191:145&#x2013;147. doi: 10.1016/j.thromres.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D, Sperhake JP, L&#xfc;tgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schr&#xf6;der AS, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study. Ann. Intern. Med. 2020;173(4):268&#x2013;277. doi: 10.7326/M20-2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazzani W, Evans L, Alshamsi F, M&#xf8;ller MH, Ostermann M, Prescott HC, Arabi YM, Loeb M, Ng Gong M, Fan E, et al. Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: First update. Crit. Care Med. 2021;49(3):e219&#x2013;e234. doi: 10.1097/CCM.0000000000004899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004899</ArticleId><ArticleId IdType="pubmed">33555780</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA, Leavitt AD, Lee AYY, Macbeth F, Morgan RL, et al. American Society of Hematology 2021 guidelines for management of venous thromboembolism: Prevention and treatment in patients with cancer. Blood Adv. 2021;5(4):927&#x2013;974. doi: 10.1182/bloodadvances.2020003442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003442</ArticleId><ArticleId IdType="pmc">PMC7903232</ArticleId><ArticleId IdType="pubmed">33570602</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021;5(3):872&#x2013;888. doi: 10.1182/bloodadvances.2020003763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003763</ArticleId><ArticleId IdType="pmc">PMC7869684</ArticleId><ArticleId IdType="pubmed">33560401</ArticleId></ArticleIdList></Reference><Reference><Citation>Musoke N, Lo KB, Albano J, Peterson E, Bhargav R, Gul F, DeJoy R, 3rd, Salacup G, Pelayo J, Tipparaju P, et al. Anticoagulation and bleeding risk in patients with COVID-19. Thromb. Res. 2020;196:227&#x2013;230. doi: 10.1016/j.thromres.2020.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.08.035</ArticleId><ArticleId IdType="pmc">PMC7444469</ArticleId><ArticleId IdType="pubmed">32916565</ArticleId></ArticleIdList></Reference><Reference><Citation>Rad F, Dabbagh A, Dorgalaleh A, Biswas A. The relationship between inflammatory cytokines and coagulopathy in patients with COVID-19. J. Clin. Med. 2021;10(9):2020. doi: 10.3390/jcm10092020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10092020</ArticleId><ArticleId IdType="pmc">PMC8125898</ArticleId><ArticleId IdType="pubmed">34065057</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, et al. Dexamethasone in hospitalized patients with COVID-19. N. Engl. J. Med. 2021;384(8):693&#x2013;704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, et al. Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern. Med. 2021;181(1):41&#x2013;51. doi: 10.1001/jamainternmed.2020.6252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.6252</ArticleId><ArticleId IdType="pmc">PMC7577201</ArticleId><ArticleId IdType="pubmed">33080002</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long COVID. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long COVID. BMJ. 2020;371:m4938. doi: 10.1136/bmj.m4938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano, J.B., Murthy, S., Marshall, J.C., Relan, P., Diaz, J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: The Berlin Definition. JAMA. 2012;307(23):2526&#x2013;2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinlinie. AdWMFA-SK: S3-Leitlinie Sepsis&#x2014;Pr&#xe4;vention, Diagnose, Therapie und Nachsorge. Online Ressource Verf&#xfc;gbar. https://www.awmforg/uploads/tx_szleitlinien/079-001k_S3_Sepsis-Praevention-Diagnose-Therapie-Nachsorge_2020-02pdf (Zugriff am 150621) 2018.</Citation></Reference><Reference><Citation>Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C, Da Silva D, Zafrani L, Tirot P, Veber B, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N. Engl. J. Med. 2018;378(21):1965&#x2013;1975. doi: 10.1056/NEJMoa1800385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1800385</ArticleId><ArticleId IdType="pubmed">29791822</ArticleId></ArticleIdList></Reference><Reference><Citation>Koczulla AR, Ankermann T, Behrends U, Berlit P, B&#xf6;ing S, Brinkmann F, Franke C, Gl&#xf6;ckl R, Gogoll C, Hummel T, et al. S1 guideline post-COVID/long-COVID. Pneumologie. 2021;75(11):869&#x2013;900. doi: 10.1055/a-1551-9734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1551-9734</ArticleId><ArticleId IdType="pubmed">34474488</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou G. A modified poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 2004;159(7):702&#x2013;706. doi: 10.1093/aje/kwh090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh090</ArticleId><ArticleId IdType="pubmed">15033648</ArticleId></ArticleIdList></Reference><Reference><Citation>Broman, L.M., Eksborg, S., Coco, V.L., De Piero, M.E., Belohlavek, J., Lorusso, R. Extracorporeal membrane oxygenation for COVID-19 during first and second waves. Lancet Respir. Med. (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8331087</ArticleId><ArticleId IdType="pubmed">34146489</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E, Bartlett RH, Tonna JE, Hyslop R, Fanning JJ, et al. Extracorporeal membrane oxygenation support in COVID-19: An international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396(10257):1071&#x2013;1078. doi: 10.1016/S0140-6736(20)32008-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32008-0</ArticleId><ArticleId IdType="pmc">PMC7518880</ArticleId><ArticleId IdType="pubmed">32987008</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, de Mendon&#xe7;a A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit. Care Med. 1998;26(11):1793&#x2013;1800. doi: 10.1097/00003246-199811000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199811000-00016</ArticleId><ArticleId IdType="pubmed">9824069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira FL, Bota DP, Bross A, M&#xe9;lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754&#x2013;1758. doi: 10.1001/jama.286.14.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.14.1754</ArticleId><ArticleId IdType="pubmed">11594901</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder I, Scharf C, Zoller M, Wassilowsky D, Frank S, Stecher S-S, Stemmler J, Kneidinger N, Peter&#xdf; S, Zwi&#xdf;ler B, et al. Charakteristika und Outcome von 70 beatmeten COVID-19-Patienten. Anaesthesist. 2021;70(7):573&#x2013;581. doi: 10.1007/s00101-020-00906-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00101-020-00906-3</ArticleId><ArticleId IdType="pmc">PMC7768596</ArticleId><ArticleId IdType="pubmed">33369696</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaji H. Adipose tissue-derived plasminogen activator inhibitor-1 function and regulation. Compr. Physiol. 2016;6(4):1873&#x2013;1896. doi: 10.1002/cphy.c160004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphy.c160004</ArticleId><ArticleId IdType="pubmed">27783862</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Xu QH. The correlation of plasma thrombomodulin plasminogen activator inhibitor-1 and endothelial cell injury in septic patients. Zhonghua Nei Ke Za Zhi. 2021;60(2):143&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">33503726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci, M., Sitzia, C., Baryshnikova, E., Di Dedda, U., Cardani, R., Martelli, F., Corsi Romanelli, M. COVID-19-associated coagulopathy: biomarkers of thrombin generation and fibrinolysis leading the outcome. J. Clin. Med. 9(11) (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7692774</ArticleId><ArticleId IdType="pubmed">33126772</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbie LA, Dummer S, Booth NA, Adey GD, Bennett B. Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis. Br. J. Haematol. 2000;109(2):342&#x2013;348. doi: 10.1046/j.1365-2141.2000.02057.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2000.02057.x</ArticleId><ArticleId IdType="pubmed">10848822</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel BV, Arachchillage DJ, Ridge CA, Bianchi P, Doyle JF, Garfield B, Ledot S, Morgan C, Passariello M, Price S, et al. Pulmonary angiopathy in severe COVID-19: Physiologic, imaging, and hematologic observations. Am. J. Respir. Crit. Care Med. 2020;202(5):690&#x2013;699. doi: 10.1164/rccm.202004-1412OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1412OC</ArticleId><ArticleId IdType="pmc">PMC7462405</ArticleId><ArticleId IdType="pubmed">32667207</ArticleId></ArticleIdList></Reference><Reference><Citation>Creel-Bulos, C., Auld, S.C., Caridi-Scheible, M., Barker, N., Friend, S., Gaddh, M., Kempton, C.L., Maier, C., Nahab, F., Sniecinski, R. Fibrinolysis shutdown and thrombosis in a COVID-19 ICU. Shock. (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8858425</ArticleId><ArticleId IdType="pubmed">32769822</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba&#xf1;ez, C., Perdomo, J., Calvo, A., Ferrando, C., Reverter, J.C., Tassies, D., Blasi, A. High D dimers and low global fibrinolysis coexist in COVID19 patients: What is going on in there? J. Thromb. Thrombolysis. 1&#x2013;5 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7363162</ArticleId><ArticleId IdType="pubmed">32671609</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright FL, Vogler TO, Moore EE, Moore HB, Wohlauer MV, Urban S, Nydam TL, Moore PK, McIntyre RC., Jr Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection. J. Am. Coll. Surg. 2020;231(2):193&#x2013;203.e191. doi: 10.1016/j.jamcollsurg.2020.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2020.05.007</ArticleId><ArticleId IdType="pmc">PMC7227511</ArticleId><ArticleId IdType="pubmed">32422349</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xe1;troch I, Smudla A, Babik B, T&#xe1;nczos K, K&#xf3;bori L, Szab&#xf3; Z, Fazakas J. Procoagulation, hypercoagulation and fibrinolytic &#x201c;shut down&#x201d; detected with ClotPro&#xae; viscoelastic tests in COVID-19 patients. Orv. Hetil. 2020;161(22):899&#x2013;907. doi: 10.1556/650.2020.31870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/650.2020.31870</ArticleId><ArticleId IdType="pubmed">32453702</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J. Diabetes Complications. 2021;35(3):107817. doi: 10.1016/j.jdiacomp.2020.107817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2020.107817</ArticleId><ArticleId IdType="pmc">PMC7690270</ArticleId><ArticleId IdType="pubmed">33358523</ArticleId></ArticleIdList></Reference><Reference><Citation>Salinas-Aguirre JE, S&#xe1;nchez-Garc&#xed;a C, Rodr&#xed;guez-Sanchez R, Rodr&#xed;guez-Mu&#xf1;oz L, D&#xed;az-Casta&#xf1;o A, Bernal-G&#xf3;mez R. Clinical characteristics and comorbidities associated with mortality in patients with COVID-19 in Coahuila (Mexico) Rev. Clin. Esp. 2022;222(5):288&#x2013;292. doi: 10.1016/j.rce.2020.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2020.12.006</ArticleId><ArticleId IdType="pmc">PMC8491924</ArticleId><ArticleId IdType="pubmed">34620580</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Wang L, Liu J, Fu S, Zhou L, Wang Y. Obesity or increased body mass index and the risk of severe outcomes in patients with COVID-19: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022;101(1):e28499. doi: 10.1097/MD.0000000000028499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000028499</ArticleId><ArticleId IdType="pmc">PMC8735775</ArticleId><ArticleId IdType="pubmed">35029905</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Torres-Macho J, Elvira-Mart&#xed;nez CM, Molina-Trigueros LJ, Sebasti&#xe1;n-Viana T, Hern&#xe1;ndez-Barrera V. Obesity is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: A multicentre case-control study. Int. J. Clin. Pract. 2021;75(12):e14917. doi: 10.1111/ijcp.14917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14917</ArticleId><ArticleId IdType="pmc">PMC8646300</ArticleId><ArticleId IdType="pubmed">34569684</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Bobkova P, Spiridonova E, Shikhaleva A, Gamirova A, Blyuss O, Nekliudov N, Bugaeva P, Andreeva M, DunnGalvin A, et al. Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin. Exp. Allergy. 2021;51(9):1107&#x2013;1120. doi: 10.1111/cea.13997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.13997</ArticleId><ArticleId IdType="pmc">PMC8444748</ArticleId><ArticleId IdType="pubmed">34351016</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, Barzegar Z, Kabiri M, Zeraatpisheh Z, Farjoud-Kouhanjani M, et al. Risk factors associated with long COVID syndrome: A retrospective study. Iran. J. Med. Sci. 2021;46(6):428&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit. Care Med. 2010;38(4 Suppl):e91&#x2013;97. doi: 10.1097/CCM.0b013e3181c92eeb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181c92eeb</ArticleId><ArticleId IdType="pubmed">19935413</ArticleId></ArticleIdList></Reference><Reference><Citation>Fichtner F, Moerer O, Weber-Carstens S, Nothacker M, Kaisers U, Laudi S. Clinical guideline for treating acute respiratory insufficiency with invasive ventilation and extracorporeal membrane oxygenation: Evidence-based recommendations for choosing modes and setting parameters of mechanical ventilation. Respiration. 2019;98(4):357&#x2013;372. doi: 10.1159/000502157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000502157</ArticleId><ArticleId IdType="pubmed">31505511</ArticleId></ArticleIdList></Reference><Reference><Citation>Sromicki J, Schmiady M, Maisano F, Mestres CA. ECMO therapy in COVID-19: An experience from Zurich. J. Card. Surg. 2021;36(5):1707&#x2013;1712. doi: 10.1111/jocs.15147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jocs.15147</ArticleId><ArticleId IdType="pubmed">33124076</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrichson, B., Kloka, J.A., Neef, V., Mutlak, H., Old, O., Zacharowski, K., Piekarski, F. Extracorporeal membrane oxygenation in coronavirus disease 2019: A nationwide cohort analysis of 4279 runs from Germany. Eur. J. Anaesthesiol. (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35180152</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang J, Lin J, Zhang E, Zhong M, Luo Y, Fu Y, Yang Y. Serum IL-6 and procalcitonin are two promising novel biomarkers for evaluating the severity of COVID-19 patients. Medicine (Baltimore) 2021;100(22):e26131. doi: 10.1097/MD.0000000000026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000026131</ArticleId><ArticleId IdType="pmc">PMC8183731</ArticleId><ArticleId IdType="pubmed">34087864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci Z, Romagnoli S. Acute kidney injury: Diagnosis and classification in adults and children. Contrib. Nephrol. 2018;193:1&#x2013;12. doi: 10.1159/000484956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484956</ArticleId><ArticleId IdType="pubmed">29393148</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz, G., Hawlik, K., Wild, C. Extracorporeal cytokine adsorption therapy as a preventive measure in cardiac surgery and as a therapeutic add-on treatment in sepsis: An updated systematic review of comparative efficacy and safety*. Crit. Care Med. 49(8) (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33935160</ArticleId></ArticleIdList></Reference><Reference><Citation>Supady A, Weber E, Rieder M, Lother A, Niklaus T, Zahn T, Frech F, M&#xfc;ller S, Kuhl M, Benk C, et al. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): A single centre, open-label, randomised, controlled trial. Lancet Respir. Med. 2021;9(7):755&#x2013;762. doi: 10.1016/S2213-2600(21)00177-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00177-6</ArticleId><ArticleId IdType="pmc">PMC8121541</ArticleId><ArticleId IdType="pubmed">34000236</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, T., Hayanga, J., Durham, L., Garrison, L., McCarthy, P., Barksdale, A., Smith, D., Bartlett, R., Jaros, M., Nelson, P. et al. CytoSorb therapy in COVID-19 (CTC) patients requiring extracorporeal membrane oxygenation: A multicenter, retrospective registry. Front. Med. 8 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8720923</ArticleId><ArticleId IdType="pubmed">34988092</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75&#x2013;87. doi: 10.1016/S0140-6736(18)30696-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30696-2</ArticleId><ArticleId IdType="pubmed">29937192</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Moreno E, Cari&#xf1;ena A, Rey T, Pita-Romero R, Leal S, Sanduende Y, Rodr&#xed;guez A, Nieto C, Vilas E, et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br. J. Anaesth. 2021;126(3):e110&#x2013;e113. doi: 10.1016/j.bja.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7833644</ArticleId><ArticleId IdType="pubmed">33413976</ArticleId></ArticleIdList></Reference><Reference><Citation>Likhvantsev, V., Landoni, G., Perekhodov, S., Chaus, N., Kadantseva, K., Ermokhina, L., Baeva, A., Yadgarov, M., Berikashvili, L., Kuzovlev, A. et al. Six-month quality of life in COVID-19 intensive care unit survivors. J. Cardiothorac. Vasc. Anesth. (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401277</ArticleId><ArticleId IdType="pubmed">34538745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadli A, Haraj NE, El Aziz S, Laidi S, Mounir A, Bensbaa S, Mjabber A, Barrou L, Hamidi EKEC, Nsiri A, et al. COVID-19: Patient care after discharge from the Intensive Care Unit. Int. J. Clin. Pract. 2021;75(9):e14270. doi: 10.1111/ijcp.14270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14270</ArticleId><ArticleId IdType="pmc">PMC8236921</ArticleId><ArticleId IdType="pubmed">34080267</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>